Showing 2051-2060 of 3201 results for "".
Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Increasing Profitability by Delivering a Better Patient Payment Experience
https://practicaldermatology.com/topics/practice-management/increasing-profitability-by-delivering-a-better-patient-payment-experience/21081/Integrated Search Marketing: The New Search Paradigm
https://practicaldermatology.com/topics/practice-management/integrated-search-marketing-the-new-search-paradigm/21510/One can say with a fair amount of certainty that the time of the Integrated Search Marketing (ISM) has arrived.Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21647/New Products and Pharmacologic Advancements
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-advancements/21663/Rosacea: Choosing Among the Topical and Systemic Therapeutic Options
https://practicaldermatology.com/topics/general-topics/rosacea-choosing-among-the-topical-and-systemic-therapeutic-options/21706/As the field of therapies available for rosacea has expanded, clinicians must weigh the topical and oral treatment options on a case-by-case basisHow to Integrate Physician-Dispensed Products
https://practicaldermatology.com/topics/general-topics/PD0609_10-php/22819/With the correct protocols, staff training, and product selection, physician dispensing can help retain your current patient base and assist in marketing to new patients.Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.Exosomes: The Next Big Thing in Skincare?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exosomes-the-next-big-thing-in-skincare/23684/There is still a lot to learn, but early evidence suggests that topically applied exosomes may transform the approach to skincare.